Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia–ischemia in mice with neuronal Fyn overexpression-Reference-Cited by-同舟云学术

Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia–ischemia in mice with neuronal Fyn overexpression

Published:2013-03 Issue: Volume:51 Page:113-119
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Knox Renatta,Zhao Chong,Miguel-Perez Dario,Wang Steven,Yuan Jinwei,Ferriero Donna,Jiang Xiangning

Publisher

Elsevier BV

Subject

Neurology

Reference42 articles.

1. A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT;Atkinson;J. Biol. Chem.,1996

2. Deletion of the fyn-kinase gene alters sensitivity to GABAergic drugs: dependence on beta2/beta3 GABAA receptor subunits;Boehm;J. Pharmacol. Exp. Ther.,2004

3. Ionic dependence of glutamate neurotoxicity;Choi;J. Neurosci.,1987

4. Effect of Src kinase phosphorylation on disordered C-terminal domain of N-methyl-d-aspartic acid (NMDA) receptor subunit GluN2B protein;Choi;J. Biol. Chem.,2011

5. A novel approach to the study of hypoxia–ischemia-induced clinical and subclinical seizures in the neonatal rat;Cuaycong;Dev. Neurosci.,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calpain: The regulatory point of cardiovascular and cerebrovascular diseases;Biomedicine & Pharmacotherapy;2024-10

2. GluN2B-containing NMDA receptor attenuated neuronal apoptosis in the mouse model of HIBD through inhibiting endoplasmic reticulum stress-activated PERK/eIF2α signaling pathway;Frontiers in Molecular Neuroscience;2024-04-04

3. The GluN2B-Containing NMDA Receptor Alleviates Neuronal Apoptosis in Neonatal Hypoxic-Ischemic Encephalopathy by Activating PI3K-Akt-CREB Signaling Pathway;Physiological Research;2023-11-20

4. Neonatal Arterial Ischaemic Stroke: Advances in Pathologic Neural Death, Diagnosis, Treatment, and Prognosis;Current Neuropharmacology;2022-12

5. Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease;European Journal of Medicinal Chemistry;2022-06